852 related articles for article (PubMed ID: 30102955)
1. CEPO-Fc (An EPO Derivative) Protects Hippocampus Against Aβ-induced Memory Deterioration: A Behavioral and Molecular Study in a Rat Model of Aβ Toxicity.
Hooshmandi E; Motamedi F; Moosavi M; Katinger H; Zakeri Z; Zaringhalam J; Maghsoudi A; Ghasemi R; Maghsoudi N
Neuroscience; 2018 Sep; 388():405-417. PubMed ID: 30102955
[TBL] [Abstract][Full Text] [Related]
2. CEPO (carbamylated erythropoietin)-Fc protects hippocampal cells in culture against beta amyloid-induced apoptosis: considering Akt/GSK-3β and ERK signaling pathways.
Hooshmandi E; Moosavi M; Katinger H; Sardab S; Ghasemi R; Maghsoudi N
Mol Biol Rep; 2020 Mar; 47(3):2097-2108. PubMed ID: 32067159
[TBL] [Abstract][Full Text] [Related]
3. Effect of carbamylated erythropoietin Fc fusion protein (CEPO-Fc) on learning and memory impairment and hippocampal apoptosis induced by intracerebroventricular administration of streptozotocin in rats.
Moosavi M; Hooshmandi E; Javadpour P; Maghsoudi N; Katinger H; Ghasemi R
Behav Brain Res; 2020 Apr; 384():112554. PubMed ID: 32057828
[TBL] [Abstract][Full Text] [Related]
4. Insulin protects against Aβ-induced spatial memory impairment, hippocampal apoptosis and MAPKs signaling disruption.
Ghasemi R; Zarifkar A; Rastegar K; maghsoudi N; Moosavi M
Neuropharmacology; 2014 Oct; 85():113-20. PubMed ID: 24881967
[TBL] [Abstract][Full Text] [Related]
5. Agmatine protects against intracerebroventricular streptozotocin-induced water maze memory deficit, hippocampal apoptosis and Akt/GSK3β signaling disruption.
Moosavi M; Zarifkar AH; Farbood Y; Dianat M; Sarkaki A; Ghasemi R
Eur J Pharmacol; 2014 Aug; 736():107-14. PubMed ID: 24769303
[TBL] [Abstract][Full Text] [Related]
6. The seed of
Sun Y; Wu A; Li X; Qin D; Jin B; Liu J; Tang Y; Wu J; Yu C
Pharm Biol; 2020 Dec; 58(1):35-43. PubMed ID: 31881157
[No Abstract] [Full Text] [Related]
7. A cAMP analog attenuates beta-amyloid (1-42)-induced mitochondrial dysfunction and spatial learning and memory deficits.
Aghsami M; Sharifzadeh M; Sepand MR; Yazdankhah M; Seyednejad SA; Pourahmad J
Brain Res Bull; 2018 Jun; 140():34-42. PubMed ID: 29605485
[TBL] [Abstract][Full Text] [Related]
8. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
[TBL] [Abstract][Full Text] [Related]
9. CART modulates beta-amyloid metabolism-associated enzymes and attenuates memory deficits in APP/PS1 mice.
Yin K; Jin J; Zhu X; Yu L; Wang S; Qian L; Han L; Xu Y
Neurol Res; 2017 Oct; 39(10):885-894. PubMed ID: 28743230
[TBL] [Abstract][Full Text] [Related]
10. Intranasal formulation of erythropoietin (EPO) showed potent protective activity against amyloid toxicity in the Aβ₂₅₋₃₅ non-transgenic mouse model of Alzheimer's disease.
Maurice T; Mustafa MH; Desrumaux C; Keller E; Naert G; de la C García-Barceló M; Rodríguez Cruz Y; Garcia Rodríguez JC
J Psychopharmacol; 2013 Nov; 27(11):1044-57. PubMed ID: 23813967
[TBL] [Abstract][Full Text] [Related]
11. Cassia obtusifolia seed ameliorates amyloid β-induced synaptic dysfunction through anti-inflammatory and Akt/GSK-3β pathways.
Yi JH; Park HJ; Lee S; Jung JW; Kim BC; Lee YC; Ryu JH; Kim DH
J Ethnopharmacol; 2016 Feb; 178():50-7. PubMed ID: 26674159
[TBL] [Abstract][Full Text] [Related]
12. Lixisenatide rescues spatial memory and synaptic plasticity from amyloid β protein-induced impairments in rats.
Cai HY; Hölscher C; Yue XH; Zhang SX; Wang XH; Qiao F; Yang W; Qi JS
Neuroscience; 2014 Sep; 277():6-13. PubMed ID: 24583037
[TBL] [Abstract][Full Text] [Related]
13. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation.
Xian YF; Mao QQ; Wu JC; Su ZR; Chen JN; Lai XP; Ip SP; Lin ZX
J Alzheimers Dis; 2014; 39(2):331-46. PubMed ID: 24164737
[TBL] [Abstract][Full Text] [Related]
14. An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease.
Rodríguez Cruz Y; Strehaiano M; Rodríguez Obaya T; García Rodríguez JC; Maurice T
J Alzheimers Dis; 2017; 55(1):231-248. PubMed ID: 27662300
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective role of astaxanthin in hippocampal insulin resistance induced by Aβ peptides in animal model of Alzheimer's disease.
Rahman SO; Panda BP; Parvez S; Kaundal M; Hussain S; Akhtar M; Najmi AK
Biomed Pharmacother; 2019 Feb; 110():47-58. PubMed ID: 30463045
[TBL] [Abstract][Full Text] [Related]
16. Free and nanoencapsulated curcumin suppress β-amyloid-induced cognitive impairments in rats: involvement of BDNF and Akt/GSK-3β signaling pathway.
Hoppe JB; Coradini K; Frozza RL; Oliveira CM; Meneghetti AB; Bernardi A; Pires ES; Beck RC; Salbego CG
Neurobiol Learn Mem; 2013 Nov; 106():134-44. PubMed ID: 23954730
[TBL] [Abstract][Full Text] [Related]
17. Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric Aβ25-35 peptide administration in mice.
Naert G; Ferré V; Meunier J; Keller E; Malmström S; Givalois L; Carreaux F; Bazureau JP; Maurice T
Eur Neuropsychopharmacol; 2015 Nov; 25(11):2170-82. PubMed ID: 26381812
[TBL] [Abstract][Full Text] [Related]
18. (-)-Epigallocatechin-3-gallate ameliorates memory impairment and rescues the abnormal synaptic protein levels in the frontal cortex and hippocampus in a mouse model of Alzheimer's disease.
Guo Y; Zhao Y; Nan Y; Wang X; Chen Y; Wang S
Neuroreport; 2017 Jul; 28(10):590-597. PubMed ID: 28520620
[TBL] [Abstract][Full Text] [Related]
19. The neuroprotective effect of agmatine against amyloid β-induced apoptosis in primary cultured hippocampal cells involving ERK, Akt/GSK-3β, and TNF-α.
Hooshmandi E; Ghasemi R; Iloun P; Moosavi M
Mol Biol Rep; 2019 Feb; 46(1):489-496. PubMed ID: 30474774
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin improves synaptic plasticity and memory deficits by decrease of the neurotransmitter release probability in the rat model of Alzheimer's disease.
Esmaeili Tazangi P; Moosavi SM; Shabani M; Haghani M
Pharmacol Biochem Behav; 2015 Mar; 130():15-21. PubMed ID: 25553822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
